argenx SE
OTC:ARGNF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
argenx SE
OTC:ARGNF
|
NL |
|
Promotora y Operadora de Infraestructura SAB de CV
F:AKY
|
MX |
|
V
|
Verisk Analytics Inc
XMUN:VA7A
|
US |
|
A
|
Asia Medical & Agricultural Laboratory & Research Center PCL
SET:AMARC
|
TH |
|
C
|
Canada Nickel Company Inc
F:4E0
|
CA |
|
D
|
DBS Group Holdings Ltd
SWB:DEVL
|
SG |
|
E
|
Eaton Corporation PLC
XMUN:3EC
|
IE |
|
Softronic AB
STO:SOF B
|
SE |
|
Meridian Energy Ltd
NZX:MEL
|
NZ |
|
V
|
VeriSign, Inc
XMUN:VRS
|
US |
|
P
|
Principal Financial Group Inc
F:PG4
|
US |
|
O
|
Oversea-Chinese Banking Corporation Ltd
SWB:OCBA
|
SG |
|
I
|
Inoue Rubber Thailand PCL
SET:IRC
|
TH |
|
O
|
Otis Worldwide Corp
F:4PG
|
US |
|
K
|
Komatsu Ltd
XMUN:KOM1
|
JP |
|
G
|
Groep Brussel Lambert NV
F:EAI
|
BE |
|
I
|
Interlink Telecom PCL
SET:ITEL
|
TH |
|
A
|
Arcelormittal South Africa Ltd
XMUN:ISC1
|
ZA |
|
I
|
Imexpharm Corp
VN:IMP
|
VN |
|
T
|
Trane Technologies PLC
SWB:2IS
|
IE |
|
Credit Agricole SA
F:XCA
|
FR |
|
C
|
Citizen Watch Co Ltd
XMUN:CTZ
|
JP |
|
British Land Company PLC
F:BLDA
|
UK |
|
N
|
NetApp Inc
XMUN:NTA
|
US |
Intrinsic Value
Is ARGNF undervalued or overvalued?
See the intrinsic value estimate for 
argenx SE and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
ARGNF looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with ARGNF’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What argenx Does
argenx is a biotechnology company that develops antibody-based medicines for serious autoimmune diseases, where the body attacks its own tissues. Its best-known product is VYVGART, a prescription therapy used by specialist doctors and hospitals to treat certain immune disorders. The company also has a pipeline of follow-on drug candidates built around the same antibody engineering platform.
- Headquarters
- Netherlands NL
- Employees
- 1 863
- IPO date
- Jul 10, 2014
argenx has a narrow economic moat
Patents covering Vyvgart’s active medicine and its uses prevent rivals from freely copying argenx’s main treatment. This protects its profits without shutting out competing medicines such as UCB’s Rystiggo and Johnson & Johnson’s Imaavy.
Read the full moat analysis
Earnings Waterfall
argenx SE
The intrinsic value for argenx SE (ARGNF) under the Base Case is hidden USD.
Compared with the current market price of 790.152 USD, the stock appears hidden.